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T cells recognize antigens as peptides bound to major histocompatibility complex
(MHC) proteins through T cell receptors (TCRs) on their surface. To recognize a wide
range of pathogens, each individual possesses a substantial number of TCRs with an
extremely high degree of variability. It remains controversial whether germline-encoded
TCR repertoire is shaped by MHC polymorphism and, if so, what is the preference
between MHC genetic variants and TCR V gene compatibility. To investigate the “net”
genetic association between MHC variations and TRBV genes, we applied quantitative
trait locus (QTL) mapping to test the associations between MHC polymorphism and TCR
β chain V (TRBV) genes usage using umbilical cord blood (UCB) samples of 201 Chinese
newborns. We found TRBV gene and MHC loci that are predisposed to interact with
one another differ from previous conclusions. The majority of MHC amino acid residues
associated with the TRBV gene usage show spatial proximities in known structures of
TCR-pMHC complexes. These results show for the first time that MHC variants bias
TRBV gene usage in UCB of Chinese ancestry and indicate that germline-encoded
contacts influence TCR-MHC interactions in intact T cell repertoires.
Keywords: TRBV gene usage, MHC genetic variations, quantitative trait locus mapping, umbilical cord blood,
TCR-MHC co-evolution
INTRODUCTION
T cell immune surveillance is critical for the health of all jawed vertebrates. Most T cells express
αβ TCRs and recognize peptides derived from digested proteins when presented at the cell surface
in MHC molecules. How αβ TCR interacts with peptide-MHC (pMHC) has been a particularly
attractive field as it may contribute to developing strategies for manipulating T cell responses in
many diseases including immunodeficiencies, tumor, autoimmune, and allergic diseases.
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Looking at the structures, TCR-pMHC interaction is a delicate
process. TCR exists in heterodimers and the binding site of
each TCR chain can be divided into three complementarity-
determining regions (CDRs), called CDR1, 2, and 3. The most
variable region CDR3 is formed by somatic recombination of the
variable (V), joining (J), and in β chains diversity (D) genes (1–
3). Less variable regions CDR1 and CDR2 loop sequences are
constant for each type of chain, and are therefore referred to as
“germline-derived.” Unlike CDR3, CDR1, and CDR2 regions are
encoded by only TCR V genes. As such, the T cell repertoire
of each individual may have a potential number of 1018 TCRs
(4). Human MHC genes are also known as human leukocyte
antigen (HLA) genes. HLA genes are extremely polymorphic
with more than 12,000 known alleles and MHC haplotypes are
highly variable in different ethnic groups (5, 6). Each individual
inherits one set of MHC genes from a parent including classical
MHC class I loci (HLA-A, -B, and -C) and classical MHC class
II loci (HLA-DP, -DQ, and -DR). In the dozens of structures
of TCR-pMHC complexes that have been solved, CDR1 and
CDR2 loops are shown to in contact with the conserved α-helical
residues of the MHC molecules, and the highly variable CDR3
loops primarily interact with the peptide (7–9).
Recently, biased αβTCR repertoires and TCR “signatures”
raised against specific antigens have been observed in various
diseases, especially in virus infections, autoimmune disorders,
and tumor (10). Little is known about whether, and if so how
MHC genotype influences the composition of TCR repertoire.
Most recently, a genetic study done by Pritchard laboratory
showed that MHC gene is the most influential gene of TCR V
gene usage using RNA-seq data from a large cohort of European
adults (11). However, there are also other pieces of evidence
suggesting that germline-encoded TCR sequences are not the
primary sites for TCR-pMHC interaction. Structural data show
that the binding energetics can focus on the CDR3 contacts with
peptide and/or the MHC alpha helices in some complexes (12,
13). In addition, there has been a long debate over whether TCRs
have been selected evolutionarily to react with MHC (7, 9, 14).
As TCR repertoire change greatly based on antigen experience,
exhaustion and peripheral T cell proliferation, especially age-
associated changes in primary and secondary lymphoid organs,
it would be interesting to see how MHC molecules affect TCR
repertoire with confounding factors in control.
Therefore, we investigated whether MHC genetic variations
reshape the intact TCR repertoires using umbilical cord blood
(UCB) to exclude any influential factors that have yet to be
introduced. Most UCB T cells are naïve cells occupied by
dominant both naïve CD4+ and naïve CD8+ T cells. Specifically,
87.6 ± 5.2% UCB CD4+ T cells co-expressed CD45RA naive
antigen and the percentage is 93.5 ± 7.8% for UCB CD8+ T
cells (15). And among all age groups, UCB T cells have the
highest TCR diversity, the largest number of pathogen-specific
clonotypes with the smallest average clonotype size (16) which
mean the least probability of biased clonal amplification caused
by environmental antigens. These features mentioned above
indicate the naive immunophenotype of UCB T cell repertoire.
We obtained UCB samples from 201 Chinese newborns, freshly
isolated the buffy coat and extracted DNAs. We then sequenced
the DNA samples for TCR β chain V genes and the MHC
region and performed QTL mapping to test the associations
between TRBV gene usage and MHC variations at three levels
of allele, nucleotide and amino acid. Our results identified TRBV
gene and MHC loci that are predisposed to interact with one
another. Contacts between MHC and TRBV molecules promote
a genotype shift in TRBV gene usage.
MATERIALS AND METHODS
Umbilical Cord Blood Collection and DNA
Isolation
Six milliliter umbilical cord blood was collected from each of
201 healthy newborns after delivery at Guangzhou Women and
Children’sMedical Center (Guangzhou city, Guangdong, China).
The sample collection was performed in accordance with the
ethical standards of the Ethics Committee of GuangzhouWomen
and Children’s Medical Center (GWCMC) and written informed
consent was obtained from all participating pregnant women.
The buffy coat of cord blood was freshly isolated with density
gradient centrifugation and DNA was extracted using the HiPure
Blood DNA Mini Kit (Magen) according to the manufacturer’s
protocol. DNA concentration and integrity were measured by
Qubit 3.0 fluorometer (Life Technologies, Paisley, UK) and
agarose gel (Agilent) electrophoresis.
Immune Repertoire Library Preparation
and Sequencing
The 1.2 µg DNA sample was partitioned to construct a library
for TCR β (TRB) chain and immune globulin heavy (IGH)
chain sequencing using a two-step-PCR method. Firstly, buffy
coat DNA was subjected to Multiplex PCR (MPCR) using
published primers and cycling conditions to enrich rearranged
complementarity determining region 3 (CDR3) of the variable
regions of TRB/IGH chain (17, 18). The second PCR introduced
the sequencing primers, Illumina primers P5 and P7, into the
first PCR products. IGH and TRB genes were sequenced on the
HiSeq 4000 (Illumina, La Jolla, CA) with the standard paired-end
150 and paired-end 100 protocol, respectively. Base calling was
performed according to the manufacturer’s instruction.
MHC Region Capture, Library
Construction, and Sequencing
MHC region capture sequencing was performed using the similar
protocol reported before (19) with the same design of MHC
capture probes named as 110729_HG19_MHC_L2R_D03_EZ,
whose product information is provided on the Roche NimbleGen
website (https://sequencing.roche.com/en/technology-research/
research/immunogenetics.html). This probe set was designed to
template upon the 8 annotated human MHC haplotypes and
to encompass the 5 megabases (Mb) of the extended MHC
region. The evaluation showed that ∼97% of the MHC region,
and over 99% of the genes in MHC region, are covered;
98% of genotypes called by this capture sequencing prove
consistent with established HapMap genotypes (19). And the
sequencing adaptors are modified to fit BGISEQ-500 sequencer
Frontiers in Immunology | www.frontiersin.org 2 August 2019 | Volume 10 | Article 2064
Gao et al. TCR-MHC Contacts Promote TRBV Bias
(BGI-Shenzhen, Shenzhen, China). In brief, the 1 µg shotgun
library was hybridized to the capture probes following the
manufacturer’s protocols (Roche NimbleGen) and the captured
target fragments were amplified using AccuPrime R© Pfx DNA
Polymerase (Invitrogen). The PCR products of captured DNA
were purified and quantified by Qubit R© dsDNA BR Assay
Kits (Invitrogen), and then used to construct sequencing
library guided by the manufacturer’s protocol (BGISEQ-500)
(20) including cyclizing and digestion with enzymes and
quantified by Qubit R© ssDNA Assay Kit (Invitrogen). Finally,
libraries were sequenced with standard paired-end 50 reads
on the BGISEQ-500 sequencer following the manufacturer’s
instructions (20).
Immune Repertoire Analysis
TRB and IGH Sequencing data were analyzed using IMonitor
(version 1.3.0) developed by our laboratory previously (17).
The whole analysis pipeline could be split into the following
steps briefly. Firstly, the basic quality control of raw reads
was performed including removing low quality reads with
average Phred Quality Score <15 and cleaned paired-end reads
were merged with their overlapped nucleotides. Secondly, the
merged data was aligned to the V, D, J germline genes and
alleles that were deposited in the IMGT database (www.imgt.
org) by the BLAST (21–23); V, D, and J gene segments were
appointed for each sequence according to its alignment result.
Thirdly, low abundance sequences with <5 support reads were
removed and the left sequences were translated into amino
acid sequences. Finally, the TCR or IGH data, such as V-J
pairing, V/J usage, CDR3 sequence frequency and CDR3 length
distribution, was counted. The average effective data is ∼2.3M
reads for both TRB (PE100) and IHG (PE150). The average
percentages of V gene alignment are 77.91 and 88.22% for TRB
and IGH, respectively.
The parameters of IMonitor used in our samples were: -ec -
k (100 for TRB or 150 for IGH) -jif 80 -vif 80 -v 33 -d and all
the parameters have been used or described in other immune
repertoire studies (17, 24, 25). To allow data analysis by QTL
mapping, undetectable TRBV and IGHV gene were defined as
zero. Log2-transformed usage of TRBV (0.01 pseudo-usage was
added to avoid zeroes for TRBV) and IGHV (0.00001 pseudo-
usage was added to avoid zeroes for IGHV) were displayed by R
code with hierarchical clustering of both rows and columns.
Variant Calling in Raw Reads of MHC
Region
For each sequenced sample, the mean coverage per bp was
67.57 times with 335.86Mb effective data, covering 93.19% of
the extended MHC region on average. MHC targeted capture
sequencing raw data was first quality controlled by filtering out
reads with more than 50% bad bases that have quality score
≤ 5, then aligned to the human reference genome sequence
(UCSC hg19) using BWA (26) (version 0.5.9). BAM files were
firstly processed by Picard (version 1.54, http://broadinstitute.
github.io/picard) to sort, merge and mark duplications, and then
were managed by Genome Analysis Toolkit (27) (GATK, version
3.4) to recalibrate bases, call variants in HaplotypeCaller mode
and recalibrate variant quality scores. Only variants labeled as
“PASS” by GATK were kept.
Imputation of MHC Alleles
Using variants called by GATK, we imputed four-digit classical
HLA alleles for HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-
DQB1, HLA-DPB1, HLA-DPA1, and HLA-DQA1 with Beagle
(28) (version 4.1). The Han-MHC reference panel (29) (total
number of individuals 10,689) was used for imputation. In the
evaluation, the aggregated mean concordance (r2 value) was 0.97
for common, 0.93 for low-frequency and 0.81 for rare HLA
alleles. Overall, the concordance rate was about 0.93 at four-digit
resolution and 0.97 at two-digit resolution when the eight most
polymorphic HLA genes were evaluated (29). For each sample
and each gene, MHC alleles with the highest genotype probability
(estimated by Beagle) were selected. SNPs corresponding to
MHC alleles were obtained by aligning exon sequences from
the IMGT/HLA database (5) to the human reference genome
sequence (UCSC hg19) using BWA (version 0.5.9). Amino acid
polymorphisms corresponding to MHC alleles were obtained by
annotation of SNPs using ANNOVAR (30) (version 2017 July 16).
QTL Mapping
The genetic variations at single nucleotide, amino acid, and four-
digit classical MHC haplotypes were coded as allelic dosage
counting on the number of reference allele/s (0, 1, 2). For
example, if an SNP is bi-allelic with A and C alleles, we take allele
A as the reference allele and count the number of A allele for
each individual and code the genotype AA, AC, and CC as 2, 1,
and 0. If an SNP is tri-allelic with three possible alleles, then we
take each of the possible alleles as reference allele and the others
as alternatives, generating three SNP IDs for each tri-allelic SNP.
For example, if an SNP has A, C, and T, then we will have three
IDs for this SNP: SNP1 will take A as the reference allele and
treat the other two alleles as alternatives, therefore, an SNP with
genotype of AA is coded as 2, AT and AC are both coded as 1,
TT and CC are both coded as 0, and so are for the other two
SNP IDs. One tri-allelic SNP is then treated as three SNPs for
further analysis.
We used the MatrixEQTL R package (31) for QTL mapping
of TRBV and IGHV genes usage with genetic variations in the
MHC region. We applied QTL mapping at three levels of genetic
variations. SNPs, polymorphic amino acids and four-digit MHC
alleles with aMAF (minor allele frequency)< 0.05 were removed.
A threshold of 5% FDR was used to control for the testing
burdens of multiple variations at each genetic level.
Conditional Analysis of Associations
Between TRBV Genes Usage and MHC
Amino Acid Variations
The Conditional analysis was performed individually for each
TRBV gene usage using forward stepwise linear regression.
We established the optimal threshold to perform the stepwise
conditional regression on amino acid variations with FDR <
0.05 from the QTL mapping and we considered an expanded
model that included the dosage variable for target amino acid
variant and the most significant amino acid variant (top amino
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acid variant) as a covariate. If the target amino acid variations
had a conditional P < 0.05, we considered it as an independent
signal (second amino acid variant). Themultiple linear regression
model then expanded to include the top amino acid variant
and the second amino acid variant as covariates and test the
association of the remaining amino acid variants. Regression
stopped when the conditional P-value of the target amino acid
variant was >0.05. We also carried out this type of analysis for
the SNPs.
Estimating the Fraction of Variation for
Each TRBV Gene Usage That Is Explained
by Genetic Variation in the MHC Locus
We fitted a linear regression or a multiple linear regression
model (when appropriate) with the target TRBV gene usage as
a dependent variable and the significant amino acid variants
identified from QTL mapping and conditional analyses as
independent variables using lm function in R. The proportion
of variability explained by the corresponding independent amino
acid variant was the adjusted R-square derived from the linear
regression model. The statistical significance of the overall model
was tested using F-tests. These analyses were also performed at
the level of SNPs.
Structure Analysis
Our QTL mapping results of a total of 96 MHC amino
acid variations were marked onto protein structures of pMHC
complexes. Structures of proteins were downloaded from the
RCSB PDB [PDB ID: 2BNQ (32), PDB ID: 4G9F (33), PDB ID:
1EFX (34), PDB ID: 4OZF (35), PDB ID: 1J8H (36)] and were
plotted with the UCSF Chimera package (37). We next collected
all structures of TCRs bound to pMHCs and all contacting
information between corresponding chains of HLA-A, HLA-B,
HLA-DRB1, HLA-DQA1, or HLA-DQB1 and any of the TCR β
chains or the presented peptides in the IMGT database (5) and
calculated the frequency of the presence of contacting amino
acid position among the analyzed TCR-pMHC complex. The
identified 96 amino acid variants were then directly compared
with TCR β and peptide contacting MHC positions.
RESULTS
TRBV Gene Usage Is Influenced by MHC
Genetic Variation
To estimate the usage of TRBV genes, we sequenced TCR β
chain V genes using DNA collected from UCB of 201 Chinese
newborns. Then we calculated the proportion of reads that
mapped uniquely to each Vβ gene of all mapped reads. TheMHC
region of the same individual was sequenced by target capture
sequencing and classical four-digit alleles were imputed from
SNP data. A schematic overview of the analysis is presented in
Figure 1A.
We extracted 48 TRBV genes in each of the 201 samples using
immune repertoire sequencing data (Supplementary Figure 1,
Supplementary Tables 1, 2). Undetected TRBV genes are
randomly scattered, which is most likely due to individual
differences. Unique alleles of 23 HLA-A, 46 HLA-B, 21
HLA-C, 28 DRB1, 16 DPB1, 4 DPA1, 14 DQB1, and 15
DQA1 are present in our cohort (Supplementary Table 3).
We then performed QTL mapping between TRBV usage
and MHC alleles. As a control, B cell Immunol Globulin
Heavy chain V (IGHV) genes, which are not expected to
interact with MHC, were analyzed in a similar pipeline.
Our results showed that the frequencies of TRBV genes,
but not the IGHV genes, are significantly associated with
MHC alleles (Figure 1B, Supplementary Tables 4, 5). We then
performedQTLmapping using single nucleotide polymorphisms
(SNPs) (Supplementary Tables 6, 7) and amino acid variations
(Supplementary Tables 8, 9) corresponding to MHC alleles.
Again, only TRBV gene usage is significantly associated with
MHC at SNP and amino acid levels (Figure 1B). These are
the first genetic evidence that TRBV gene usage is significantly
influenced by MHC genes in UCB T cell repertoires.
TRBV Genes Differ in Their Association
With Different MHC Locus
Next, we aim to find which TRBV genes and MHC variants
are most likely to be in strong associations. Our results show
that the frequencies of 8.3% (4/48) of TRBV genes can be
explained by MHC alleles and the frequencies of 14.6% (7/48) of
TRBV genes can be explained by MHC nucleotide and/or amino
acid variations (Figure 2A). Among the seven TRBV genes
influenced by MHC, TRBV13, TRBV7-6, TRBV7-9, TRBV10-
3, and TRBV30 are novel; TRBV20-1 and TRBV9 have been
described before in European adults (11). In accordance with the
previous report, our results indicate that TCR V genes differ in
their compatibilities with MHC polymorphism.
Looking at the distribution of significant associations at
different MHC loci, 9 MHC alleles, 114 MHC SNPs and 96
MHC amino acid variations are associated with TRBV usage at
FDR<0.05 (Supplementary Tables 4, 6, 8). MHC class I locus
HLA-A and MHC class II locus DRB1 each have a larger number
of variations associated with TRBV genes than that of any other
loci of the same class at both nucleotide and amino acid level
(Figures 2B,C). If the specificity of TCRs towardMHCmolecules
depends on only the conservative regions of MHC molecules,
then we may expect to find the number of TCR associated MHC
molecules to be approximately proportional to the number of
MHC variations in each region. Interestingly, HLA-C locus has
the minimum number of variations in association with TRBV
genes despite the fact that the degree of HLA-C loci diversity
is as high as that of HLA-A loci. Although HLA-C shares
sequence homology with HLA-A and HLA-B molecules, it is
substantially different from other MHC I molecules in many
different ways. One of the main feature distinguishing HLA-C is
its low expression, that the number of surface HLA-C proteins
are estimated to be only ∼10% of that of HLA-A and HLA-B
molecules (38–40). Thus, it is highly possible TCR usage bias
explained by different MHC loci is also shaped by the intrinsic
differences in the abundance of surfaceMHCproteins, suggesting
a strong influence from direct physical contacts.
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FIGURE 1 | The frequencies of TRBV genes are significantly associated with variations in the MHC locus. (A) Schematic overview of the analysis. Usage of TCR β
chain V genes was estimated by mapping buffy coat DNA sequencing reads to the human TRBV gene database. MHC alleles were imputed with Beagle. SNPs were
called using BWA (version 0.5.9). Amino acid polymorphisms corresponding to MHC alleles were obtained by annotation of SNPs using ANNOVAR. The associations
of Vβ usage with nucleotide and amino acid genotypes were tested by QTL mapping using a linear regression model. (B) QQ plots for the associations between MHC
alleles/SNPs/amino acid variations and the usage of TRBV genes (up) or IGHV genes (down). The red line refers to a normal distribution; each black dot represents
one allele/SNP/amino acid variation. Estimated inflation factor lambda is provided if it is statistically significant.
Independent MHC Residues That Bias
TRBV Gene Usage
Due to the strong linkage disequilibrium (LD) structure in the
MHC region, it is unclear which MHC variant is responsible
for a particular association. Therefore, we performed conditional
analysis for each TRBV genes to identify their potential
independent MHC amino acid variants. For instance, we
examined all TRBV13-associated MHC amino acids. Twenty
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FIGURE 2 | TRBV genes differ in their association with different MHC locus. (A) TRBV gene usage explained by MHC alleles (yellow), nucleotide, and amino acid
variations of the MHC alleles (blue). The associations of Vβ gene usage with the number of nucleotide variations (B), and with the number of amino acid variations (C)
(FDR ≤ 0.05). SNPs are binned according to their genomic position.
polymorphic amino acids in HLA-A, five in HLA-B and one
in HLA-DRB1 (position 71) showed significant association with
TRBV13 (FDR<0.05). Except HLA-A position 97 and HLA-
DRB1 position 71, other amino acid positions initially have four
potential linkage groups (Figure 3A). Our conditional analysis
further confirmed that amino acid position 97 of HLA-A have
the strongest association with TRBV13, followed by position
71 of HLA-DRB1 (Figures 3B, C, conditional P < 0.05). After
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FIGURE 3 | Independent associations between TRBV usage and amino acids variations in MHC alleles. (A) The heat map representing a color-coded correlation
matrix of all the 26 MHC amino acids that are significantly associated with TRBV13 usage (FDR ≤ 0.05). The frequencies of TRBV13 influence by the two independent
amino acid variations at HLA-A residue 97 (B) and HLA-DRB1 residue 71 (C). (D) The number of the independent Vβ gene associated MHC amino acid variations. (E)
Variation of TRBV gene usage explained by MHC amino acids variations of the MHC alleles. Values were adjusted R-square derived from the linear regression model.
A star indicates that the total proportion of variation explained by the MHC gene components was significant at 5% FDR.
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TABLE 1 | Usage variation of TRBV genes explained by independent amino acid variations in the MHC locus.
TRBV
gene ID
Top signal Second signal % of usage variation
explained by top
signal
% of usage variation
explained by second
signal
% of usage variation
explained by both
signals
TRBV20-1 HLA-DRB1.I67F HLA-A.D116Y 17.68110065 7.374011699 23.3005267
TRBV13 * HLA-A.I97M HLA-DRB1.A71R 12.5520188 7.0425016 17.0733699
TRBV7-6* HLA-B.V282I NA 8.74398907 NA 8.74398907
TRBV7-9* HLA-B.E45K HLA-DQB1.L75V 6.829646821 6.589435636 12.4010995
TRBV10-3* HLA-DRB1.D57S HLA-DQA1.A199T 7.061965751 6.994849504 15.6205873
TRBV9 HLA-A.L276P NA 6.729255542 NA 6.72925554
TRBV30* HLA-DQB1.R55P NA 6.468371558 NA 6.46837156
*TRBVs are novel findings from our data.
conditioning for these two top positions, no other associations
reach a significant level.
Using this method, 11 independent amino acid variants are
found to have the highest possibilities of influencing TRBV
gene usage (Figure 3, Supplementary Figure 2). Three of the 11
independent amino acid variations, HLA-DRB1 residue 67 and
71, HLA-DQB1 residue 55 are associated with type 1 diabetes,
multiple sclerosis, hypothyroidism, rheumatoid arthritis, and
inflammatory polyarthritis according to PheWAS database (41,
42). We showed the number of independent amino acid
variations located in specific MHC genes and the number
is comparable between class I and II (Figure 3D). Then, we
estimated to what extent these MHC variants can influence each
TRBV gene usage variation using multiple linear regression.
The results showed that 6–23.3% of the proportion of TRBV
variability can be explained by MHC amino acid variations,
highlighting an important role of MHC in shaping TCR
repertoires (Figure 3E, Table 1).
TRBV Gene Associated MHC Amino Acids
Locate in TCR Binding Pockets
MHC residues near the contact interface between TCR and
MHC or located in the polymorphic “pockets” of the peptide-
binding grooves are most likely to influence the TCR-pMHC
(peptide-major histocompatibility complex) interaction (9). To
see whether TRBV gene associated MHC residues are adjacent
to or have direct contacts with TCRs on the molecular structure,
we mapped these MHC residues onto protein structures of
pMHC complex downloaded from PDB database (Figure 4A).
We then collected all structural information of TCR-pMHC
complex consisting of 66 HLA-A, 23 HLA-B, 12 HLA-DRB1, 8
HLA-DQA1, or 8 HLA-DQB1 and their paired TCR and peptides
(Supplementary Table 10). The residues with a high possibility
of influencing TRBV gene usage tend to be either physically
near or in direct contact with the TCR in structures (Figure 4B).
For instance, HLA-DRB1 residue at position 67 predicted in
our model with the highest association with TRBV20-1 showed
contact with TCR in 42% analyzed complex and with peptide
in 75% analyzed complex. These results suggest that MHC
amino acid residues influence TCR-pMHC interactions via direct
physical contacts.
DISCUSSION
Our results show that MHC polymorphism plays an important
role in shaping UCB TCR repertoires. 14.6% (7/48) of TRBV
genes are significantly associated with nucleotide and/or amino
acid variations of the MHC molecules. Among these TRBV
associated MHC loci, we are able to pinpoint 11 independent
influential MHC amino acid residues, the majority of which are
located in HLA-A and HLA-DRB1 loci. The structural analysis
confirmed that the majority of TRBV associated MHC residues
are positioned at the TCR-pMHC contact interfaces of known
protein complexes, which indicates that MHC molecules have a
higher probability of influencing TRBV gene frequencies through
physical contacts. In summary, we conclude that MHC variations
sculpt UCB TRBV gene repertoires by favoring more compatible
TCR-MHC pairs in thymic selection.
Our results shed light on the long debate about the basis of
TCR specificity for MHCmolecules. In 1971, Jerne proposed that
TCR andMHC genes coevolve to have inherent predisposition to
interact with one another (43). Jerne’s idea was further extended
that TCRs’ biases for MHC are dictated by conserved CDR1 and
CDR2 loops encoded by TCR V genes (44), which was later
validated in many known TCR-pMHC complexes (7, 45–48).
In contradiction to this theory, a human TCR complex with an
MHC class II molecule demonstrated no dependent of CDR1 and
CDR2 for MHC recognition (12). In this complex, CDR1 and
CDR2 have a few contacts with any kind of MHC, and CDR3s
have extensive contacts with the peptide and the α helices (12). It
is currently impossible, or probably unnecessary, to thoroughly
exam all possible TCR-pMHC structures to conceive the rules for
TCR-pMHC interactions. Our results provided genetic evidence
that intrinsic TCR-MHC bias exists in the UCB samples of a
relatively large cohort of newborns. A recent study consistent
with this idea comes from Pritchard laboratory, which utilized
RNA-seq data from adult peripheral blood (11). In summary,
our genetic results are supportive of the inherited reactivity of
TCR-MHCmolecules.
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FIGURE 4 | The associated MHC residues tend to be at the TCR-pMHC interface. (A) Mapping MHC amino acids biasing the TRBV genes usage (red and yellow)
onto a structure of MHC genes (cyan) with CDR1 β chain (orange) and CDR2 β chain (green) (PDB ID from left to right: 2BNQ, 4G9F, 4OZF, and 1J8H). (B)
Comparison of the Log10-transformed P-values for the QTL analysis (left in each panel) and the frequency with which these amino acids physically contact the TCR β
chain V region (middle in each panel) or the Peptide (right in each panel) in solved complexes (from left to right: 66 HLA-A complexes, 23 HLA-B complexes, 8
HLA-DQA1 complexes, 8 HLA-DQB1 complexes, and 12 HLA-DRB1 complexes).
Previous studies on the TCR bias for MHC molecules
have utilized adult peripheral blood samples of mouse and
human. When using adult samples, precautions need to be
taken into consideration to exclude confounding factors that
may substantially shape T cell repertoire. Two such factors are
the thymic involution during aging and prevalent pathogen
infections. To minimize any known and unknown confounding
factors, we utilized the newborns’ UCB samples that allow
us to assess the “net” genetic association between TCR and
MHC. The results of our UCB data differ from previous data:
HLA-A and HLA-B, instead of HLA-C genes, are found to be
the most influential MHC class I loci to TRBV gene usage.
Although the conservative regions of HLA-C proteins are similar
to that of HLA-A and HLA-B proteins, HLA-C is substantially
different from other MHC I molecules, especially the surface
expression of HLA-C proteins is much lower than those of
the HLA-A and HLA-B proteins (49). In addition, only a
minority of CD8T cells are restricted by HLA-C, and they
have recently been found to be critical in response to chronic
infections such as Epstein-Barr virus and HIV infection (50).
Therefore, the associations between HLA-C and TCRs found
in the circulation of adults may be biologically meaningful,
but may also reflect the prevalence of HLA-C restricted
T cell responses.
It is interesting that several MHC loci stand out as more
influential than other loci in shaping TRBV genes. There may
be important biological meanings in the selective involvement of
certain MHC loci in thymic education. The conventional TCR-
MHC system is not the only function of the MHC genes or
necessarily the original function from an evolution point of view.
For instance, many non-classical MHC class I molecules, as well
as HLA-C, also function as a ligand for killer immunoglobulin
receptors (KIRs) to regulate nature killer (NK) cell activities.
Crystal structures of the KIR2DL2-HLA-Cw3 and KIR2DL1-
HLA-Cw4 complexes revealed the precise contacting site of HLA-
C with KIR molecules, which is predicted to result in KIR
competing with TCR forHLA-C interaction (40). Similarly, in the
risk predictions of MHC mismatching transplantations, HLA-
A, -B, -C, and -DRB1 mismatches are associated with higher
risks of graft-vs.-host response than those of other classical MHC
loci (51). Together, these results suggest a modification to the
applicable MHC loci of the coevolution theory.
With regard to the TRBV genes, we found seven MHC
biased TRBV genes among which, TRBV13, TRBV7-6, TRBV7-
9, TRBV10-3, and TRBV30 are first reported, and TRBV20-
1 and TRBV9 have been described before in European adults
(11). Notably, structures that composed of TRBV13 has been
extensively studied in mouse. Complexes that include TRBV13-2
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show that amino acids in its CDR2 loop react with related sites
on the MHCII α1 helix despite various docking angles of the
TCR, and TRBV13-1 CDR1 and CDR2 loops have more than
one docking site on α1 helix and shifts according to docking
positions (52). A dynamic interplay between TCR and MHC
molecules has gathered more and more evidence. It is possible
that we could eventually construct a list of conserved interactions
between TCR and MHC with genetic studies, even though, the
two molecules may not interact in a conventional way. One
of our limitations is that although we identified the significant
associated MHC residues with TRBV gene and explored the
structural mechanism, we did not calculate the preference for
contact with MHC molecules from the perspective of specific
amino acids of TCR. It is therefore not structurally validated
and compared to our current results from the MHC amino acid
perspective. And we think it would be a novel field or an inspiring
perspective to be developed further.
In summary, our results showed that TCR Vβ genes are
significantly associated with the MHC genotypes in the UCB
from a cohort of 201 Chinese newborns. Our structure analysis
suggests thatMHC amino acid residues associated with the TRBV
gene usage are in contact or adjacent with the TCRβ chains
in physical structure showing the substantial potential of MHC
to influence TCR in protein-protein interaction. Our results
confirm and extend our knowledge of TCR-MHC association
and contribute to the richness of side-by-side comparisons of
population-based studies as a strategy to further understanding
the nature of TCR-MHC interactions and its implications
in human.
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